Viewing Study NCT00113334

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:24 AM
Ignite Modification Date: 2025-12-27 @ 5:51 AM
Study NCT ID: NCT00113334
Status: COMPLETED
Last Update Posted: 2014-08-07
First Post: 2005-06-07
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and Neck Cancer
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Head and Neck Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Head and Neck Cancer View
None Thrombospondin Analogue View
None ABT-510 View
None Antiangiogenic agent View
None Lung View
None Skin View
None Thyroid View